It is well known that high levels of endogenous estrogen mediates endometrial thickening in patients with increased body fat. However, the relative contribution of low/high BMI on the endometrial response to exogenous estrogen supplementation is less understood. This study seeks to assess whether patients with extremely low BMIs are able to achieve adequate endometrial thickness and optimal clinical outcome in response to exogenous endometrium in synthetic ART cycles.
Objective:
It is well known that high levels of endogenous estrogen mediates endometrial thickening in patients with increased body fat. However, the relative contribution of low/high BMI on the endometrial response to exogenous estrogen supplementation is less understood. This study seeks to assess whether patients with extremely low BMIs are able to achieve adequate endometrial thickness and optimal clinical outcome in response to exogenous endometrium in synthetic ART cycles.
Design:
Retrospective cohort analysis
Materials and Methods:
All patients undergoing endometrial preparation for a euploid embryo transfer (ET) in a synthetic cycle from January 2005 to March 2016 were included. Patients with uterine-factor infertility (ie. history of Asherman's syndrome, submucosal fibroid or uterine septum) were excluded. Patients were stratified by WHO's BMI categories (≤17, 18-19, 20-21, 22-24, ≥25) . Maximal endometrial thickness achieved and numbers of days of estrogen supplementation required before ET were analyzed. Clinical outcomes included implantation, clinical pregnancy rate and the rate of early pregnancy loss. Data was analyzed by Kruskal-Wallis, Pearson correlation, linear and binary logistic regression.
Results:
A total of 3858 synthetic cycles were evaluated. Baseline demographics and cycle characteristics are shown in Table 1 
Conclusions:
Patients with extremely low BMI attain lower maximal endometrial thickness compared with normal BMI patients who receive a similar duration of exogenous estrogen supplementation. The hypoestrogenized state of very thin patients may lead to a marked reduction in estrogen receptor induction within the endometrium, limiting the effect of exogenous estrogen. However, these patients and their clinicians can be reassured by the fact that this altered physiology was not seen to adversely impact the probability of achieving clinical pregnancy.
Support:
None. 
